Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Tampa, FL
NPI: 1174767917Primary Practice Location
ST ANTHONYS HOSPITAL
1200 7th Ave N, St Petersburg, FL
Primary Employer
Baycare Medical Group, Inc.
baycare.org
HQ Phone
Get M.D. Ahmad's Phone NumberMobile
Get M.D. Ahmad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2015 - 2027
NY State Medical License
2013 - 2016
CT State Medical License
2012 - 2013
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
Fellowship • Hematology and Medical Oncology
2012 - 2015
Stony Brook Medicine/University Hospital
Residency • Internal Medicine
2009 - 2012
St. George's University School of Medicine
Medical School
Until 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 345 | 569 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 249 | 708 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 177 | 227 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 166 | 193 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 146 | 448 |
Authors: Don Eslin, Panida Sriaroon, Zeinab Afify, John Bohnsack, Jolan Walter, Emma Westermann-Clark, Irmel Ayala
Journal: J Clin Immunol
Publication Date: 2024-01-17
Authors: Don Eslin, Panida Sriaroon, Zeinab Afify, John Bohnsack, Priya Patel, Sonia Joychan, Jolan Walter, Emma Westermann-Clark, Irmel Ayala
Journal: J Clin Immunol
Publication Date: 2024-02-29
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Bevacizumab, DRUG: Oxaliplatin, DRUG: Irinotecan, DIETARY_SUPPLEMENT: Cholecalciferol, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Naloxegol
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI), Cancer Prevention Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Eflornithine plus sulindac, DRUG: Eflornithine placebo & sulindac placebo, DRUG: eflornithine & sulindac placebo, DRUG: Eflornithine placebo & sulindac
